Cocoa is recognized worldwide for its health-promoting properties, mainly attributed to its high phenolic compound content. Cocoa proteins, albeit a minor fraction, could present interesting food and nutrition applications. However, to date, few studies report information about it. This work aimed to investigate the cocoa protein fraction as a source of bioactive peptides. The bioactive potential of cocoa proteins and their sensory profile, allergenicity, and bioactive peptides released during gastrointestinal protein hydrolysis were analyzed using in silico techniques. Proteins already-known sequences (30 in total) were retrieved from public databases. Cocoa proteins primarily showed potential bitter (29–51%) and sweet (15–30%) flavor sequences. None of the studied proteins exhibited predicted allergenicity. Cocoa proteins' degree of hydrolysis increased from the gastric (4–21%) to the intestinal (27–51%) phase. Consequently, most bioactive peptides were released after gastrointestinal digestion. The peptides released after in silico digestion showed antidiabetic (DPP-IV inhibition), antihypertensive (ECA inhibition), and antioxidant activities. These biological activities were associated with the presence of Leu, Pro, and Val (antidiabetic), Ala, Gly, and Val (antihypertensive), and Ala, Trp, and Tyr (antioxidant). Most bioactive peptides (56–63%) exhibited high gastrointestinal absorption. The results proved that cocoa could be used as a protein source and potentially bioactive peptides to prevent cardiometabolic diseases.